JSPR vs. NGS

Last updated Apr 1, 2026

Compare and contrast key facts about Jasper Therapeutics, Inc. (JSPR) and Natural Gas Services Group, Inc. (NGS).

Performance

JSPR vs. NGS - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Jasper Therapeutics, Inc. (JSPR) and Natural Gas Services Group, Inc. (NGS). The values are adjusted to include any dividend payments, if applicable.

JSPR vs. NGS - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021
JSPR Jasper Therapeutics, Inc.	-52.12%	-91.44%	170.98%	63.39%	-93.85%	-48.08%
NGS Natural Gas Services Group, Inc.	12.49%	26.53%	66.67%	40.31%	9.46%	12.22%

Fundamentals

Market Cap JSPR : $13.44M NGS : $479.11M
EPS JSPR : -$4.23 NGS : $1.57
PB Ratio JSPR : 3.24 NGS : 1.74
Total Revenue (TTM) JSPR : $0.00 NGS : $172.32M
Gross Profit (TTM) JSPR : $0.00 NGS : $100.54M
EBITDA (TTM) JSPR : -$82.69M NGS : $65.79M

Returns By Period

In the year-to-date period, JSPR achieves a -52.12% return, which is significantly lower than NGS's 12.49% return.

JSPR

• 1D: -2.64%
• 1M: -36.51%
• YTD: -52.12%
• 6M: -63.18%
• 1Y: -79.62%
• 3Y*: -63.55%
• 5Y*: —
• 10Y*: —

NGS

• 1D: -1.20%
• 1M: -1.36%
• YTD: 12.49%
• 6M: 35.71%
• 1Y: 73.62%
• 3Y*: 54.67%
• 5Y*: 32.19%
• 10Y*: 6.14%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

JSPR vs. NGS — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

JSPR

JSPR Risk / Return Rank: 8
JSPR Sharpe Ratio Rank: 8
JSPR Sortino Ratio Rank: 7
JSPR Omega Ratio Rank: 6
JSPR Calmar Ratio Rank: 6
JSPR Martin Ratio Rank: 14

NGS

NGS Risk / Return Rank: 86
NGS Sharpe Ratio Rank: 88
NGS Sortino Ratio Rank: 83
NGS Omega Ratio Rank: 85
NGS Calmar Ratio Rank: 87
NGS Martin Ratio Rank: 90

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

JSPR vs. NGS - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Jasper Therapeutics, Inc. (JSPR) and Natural Gas Services Group, Inc. (NGS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	JSPR	NGS	Difference
Sharpe ratio Return per unit of total volatility	-0.84	1.72	-2.55
Sortino ratio Return per unit of downside risk	-1.35	2.25	-3.60
Omega ratio Gain probability vs. loss probability	0.81	1.33	-0.52
Calmar ratio Return relative to maximum drawdown	-0.92	3.26	-4.19
Martin ratio Return relative to average drawdown	-1.33	10.41	-11.74
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

JSPR vs. NGS - Sharpe Ratio Comparison

The current JSPR Sharpe Ratio is -0.84, which is lower than the NGS Sharpe Ratio of 1.72. The chart below compares the historical Sharpe Ratios of JSPR and NGS, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	JSPR	NGS	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-0.84	1.72	-2.55
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	—	0.73	—
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	0.13	—
Sharpe Ratio (All Time) Calculated using the full available price history	-0.28	0.19	-0.47

Correlation

The correlation between JSPR and NGS is 0.06, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

JSPR vs. NGS - Dividend Comparison

JSPR has not paid dividends to shareholders, while NGS's dividend yield for the trailing twelve months is around 0.85%.

	TTM	2025
JSPR Jasper Therapeutics, Inc.	0.00%	0.00%
NGS Natural Gas Services Group, Inc.	0.85%	0.62%

Drawdowns

JSPR vs. NGS - Drawdown Comparison

The maximum JSPR drawdown since its inception was -99.47%, which is greater than NGS's maximum drawdown of -89.59%. Use the drawdown chart below to compare losses from any high point for JSPR and NGS.

Drawdown Indicators

	JSPR	NGS	Difference
Max Drawdown Largest peak-to-trough decline	-99.47%	-89.59%	-9.88%
Max Drawdown (1Y) Largest decline over 1 year	-87.15%	-23.09%	-64.06%
Max Drawdown (5Y) Largest decline over 5 years	—	-40.89%	—
Max Drawdown (10Y) Largest decline over 10 years	—	-87.91%	—
Current Drawdown Current decline from peak	-99.47%	-5.22%	-94.25%
Average Drawdown Average peak-to-trough decline	-88.02%	-47.82%	-40.20%
Ulcer Index Depth and duration of drawdowns from previous peaks	60.42%	7.24%	+53.18%

Volatility

JSPR vs. NGS - Volatility Comparison

Jasper Therapeutics, Inc. (JSPR) has a higher volatility of 20.66% compared to Natural Gas Services Group, Inc. (NGS) at 11.01%. This indicates that JSPR's price experiences larger fluctuations and is considered to be riskier than NGS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	JSPR	NGS	Difference
Volatility (1M) Calculated over the trailing 1-month period	20.66%	11.01%	+9.65%
Volatility (6M) Calculated over the trailing 6-month period	56.51%	23.26%	+33.25%
Volatility (1Y) Calculated over the trailing 1-year period	95.54%	43.04%	+52.50%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	245.98%	44.07%	+201.91%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	245.98%	46.38%	+199.60%

Financials